Published on 4 May 2023 on Zacks via Yahoo Finance
Immuneering Corporation (IMRX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.56%. A quarter ago, it was expected that this company would post a loss of $0.58 per share when it actually produced a loss of $0.50, delivering a surprise of 13.79%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.